922 results on '"Farré, Magí"'
Search Results
2. Challenges encountered in the enantioselective analysis of new psychoactive substances exemplified by clephedrone (4-CMC)
3. Substance use disorders and cooperative research on addictions: Spanish approach as a model
4. Bioethics in Biomedical Research
5. Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS
6. Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial
7. Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids
8. La nueva moda de consumo de algunos inhalantes: riesgos y alerta por la falsa inocuidad
9. Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid
10. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder
11. Drug and MDMA Interactions Implications for Public Health
12. Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World
13. Addiction of Hallucinogens, Dissociatives, Designer Drugs and 'Legal Highs': Update on Potential Therapeutic Use
14. Opioid Addiction and Treatment
15. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
16. UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis
17. Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the mediterranean area: A retrospective cohort study
18. Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual
19. Trabajos de fin de grado sobre humanidades en tres estudios de ciencias de la salud
20. Challenges Encountered in the Enantioselective Analysis of New Psychoactive Substances Exemplified by Clephedrone (4-Cmc)
21. Cinemeducation in clinical pharmacology: using cinema to help students learn about pharmacovigilance and adverse drug reactions
22. Therapeutic potential of ayahuasca in grief: a prospective, observational study
23. The new trend of some inhalant use: Risks and warnings of false harmlessness
24. Clinical Pharmacology of the Synthetic Cathinone Mephedrone
25. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?
26. The efficacy of computerized interventions to reduce cannabis use: A systematic review and meta-analysis
27. The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin
28. Meconium Biomarkers of Prenatal Alcohol Exposure
29. List of Contributors
30. Addiction to Hallucinogens, Dissociatives, Designer Drugs and 'Legal Highs'
31. Opioid Addiction: Short- and Long-Acting Opioids
32. Talidomida, la historia continúa
33. GC–MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study
34. Thalidomide, the story goes on
35. Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
36. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
37. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder
38. Analysis of free hydroxytyrosol in human plasma following the administration of olive oil
39. Clinical Effects of 2C-B Abuse
40. Fentanyl and Related Opioids
41. Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity
42. Pharmacological effects of methylone and MDMA in humans
43. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart
44. Conditioned Fear Acquisition and Generalization in Generalized Anxiety Disorder
45. Anomalous brain functional connectivity contributing to poor adaptive behavior in Down syndrome
46. Pharmacokinetics of Mephedrone and Its Metabolites in Human by LC-MS/MS
47. Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism
48. Effect of olive oil phenolic compounds on the expression of blood pressure-related genes in healthy individuals
49. Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota
50. Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.